Editas Medicine, Inc.

NASDAQ:EDIT

Biotechnology

Healthcare
$1.83 +2.65%

+$0.07 today

Market cap
$281.67M
Beta
2.10
P/E (TTM)
-2.4
EPS (TTM)
-$1.11
52W Low $1.66High $4.54

Volume 2.02M

Average 2.06M

Price history

Editas Medicine, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-30.34%

Period high

$3.75

Period low

$1.67

Latest

$1.83

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 13, 2026Nov 13, 2026
4Nov 13, 2026Nov 13, 2026
8-KNov 9, 2026Nov 9, 2026
10-QNov 9, 2026Nov 9, 2026
4Nov 6, 2026Nov 6, 2026
4Nov 6, 2026Nov 6, 2026
SC 13GOct 27, 2026Oct 27, 2026
8-KOct 8, 2026Oct 8, 2026
4Sep 9, 2026Sep 9, 2026
S-8Sep 9, 2026Sep 9, 2026
3Sep 9, 2026Sep 9, 2026
EFFECTSep 8, 2026Sep 9, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026

Competitors

Who does Editas Medicine, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about EDIT's filings, answered from its disclosures.

What is the latest EDIT filing?

The latest filing shown is 4 dated Nov 13, 2026.

How many recent filings does EDIT have?

Intrinsic Alpha currently shows 20 recent filings for EDIT.